FMR »

Transcode Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by FMR from 13F filings

Historical chart of FMR investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.4k 706 6.21
2025-06-30 $23 3 7.67

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ge Vernova (GEV)
Exxon Mobil Corporation (XOM)
Ge Aerospace Com New (GE)

View all positions for FMR

Top funds holding Transcode Therapeutics

Yorkville Advisors Global
Vanguard Capital Management
Vanguard Fiduciary Trust
UBS Group
Mercer Global Advisors
FMR
Tower Research Capital
Wells Fargo & Company
SBI Securities

View all funds holding Transcode Therapeutics